Increased Risks of Developing Anxiety and Depression in Young Patients With Crohn's Disease

OBJECTIVES:Crohn's disease (CD) is associated with substantial psychosocial burden and increased risks for mental health disorders. This retrospective cohort study compared the risks of developing anxiety disorders and depression and incidences of psychotropic medication use between young CD patients and matched CD-free controls.METHODS:Medical claims, prescription drug claims, enrollment, and demographic data for patients <18 years diagnosed with CD were obtained from the MarketScan database (1 January 2000–30 June 2006). Each CD patient was matched with five CD-free controls based on exact age, sex, and months of health plan enrollment. Incidence rates and risks of developing anxiety disorders and depression and psychotropic medication use in the 6 months after the index date were compared, as were risks of developing persistent anxiety or depression (receiving medical services related to a diagnosis of anxiety or depression or psychotropic therapy for >1 year).RESULTS:After adjustment for patient characteristics, the risks of developing anxiety disorders (hazard ratio (HR) [95% confidence interval (CI);[equals;2.28 [1.65–3.17]) and depression (HR [95% CI;[equals;1.74 [1.35–2.25]) after CD diagnosis were significantly greater for the CD cohort (N=2,144) than for CD-free controls (N=10,720). Patients with CD also had greater risks of developing persistent anxiety and persistent depression (HR [95% CI;[equals;4.35 [2.22–8.50] and 2.75 [1.73–4.38], respectively).CONCLUSIONS:Compared with matched CD-free controls, young patients with CD had significantly greater risks of developing anxiety disorders and depression, were more likely to receive psychotropic treatments, and had significantly greater risks of developing persistent anxiety and depression.

[1]  E. Capristo,et al.  Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. , 1997, Scandinavian journal of gastroenterology.

[2]  P. Schoenfeld,et al.  The epidemiology and natural history of Crohn’s disease in population‐based patient cohorts from North America: a systematic review , 2002, Alimentary pharmacology & therapeutics.

[3]  M. Cheang,et al.  A Prospective Population-Based Study of Triggers of Symptomatic Flares in IBD , 2010, The American Journal of Gastroenterology.

[4]  G. Lip,et al.  The prevalence and persistence of depression and anxiety following myocardial infarction. , 2002, British journal of health psychology.

[5]  A. Figueiras,et al.  Psychological impact of Crohn's disease on patients in remission: anxiety and depression risks. , 2009, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[6]  K. Gauvreau,et al.  Depressive Symptoms and Inflammatory Bowel Disease in Children and Adolescents: A Cross-Sectional Study , 2004, Journal of pediatric gastroenterology and nutrition.

[7]  J. Varni,et al.  Fatigue and health-related quality of life in pediatric inflammatory bowel disease. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  L. Lix,et al.  The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  I. Engström.  Mental health and psychological functioning in children and adolescents with inflammatory bowel disease: a comparison with children having other chronic illnesses and with healthy children. , 1992, Journal of child psychology and psychiatry, and allied disciplines.

[10]  J. Lewis,et al.  Incidence and Prevalence of Inflammatory Bowel Disease in a Northern California Managed Care Organization, 1996–2002 , 2008, The American Journal of Gastroenterology.

[11]  P. Gaburri,et al.  Psychological distress in Brazilian Crohn's disease patients: screening, prevalence, and risk factors. , 2009, Medical science monitor : international medical journal of experimental and clinical research.

[12]  D. Pine,et al.  Adolescent depressive symptoms as predictors of adult depression: moodiness or mood disorder? , 1999, The American journal of psychiatry.

[13]  P. Simpson,et al.  A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease. , 2010, Journal of pediatric psychology.

[14]  Ken Kleinman,et al.  The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[15]  J. M. de Carpi.  [Psychosocial features of inflammatory bowel disease in the pediatric age group: acceptance of and adaptation to the disease]. , 2009, Gastroenterologia y hepatologia.

[16]  G. Fritz,et al.  Psychological considerations of the child with asthma. , 2011, Pediatric clinics of North America.

[17]  W. Riley,et al.  Hopelessness and persistence of depression in an inpatient sample , 1992, Cognitive Therapy and Research.

[18]  William J. Tremaine,et al.  Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000 , 2007, Inflammatory bowel diseases.

[19]  E. Capristo,et al.  State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting , 2008, International journal of clinical practice.

[20]  M J Goldacre,et al.  Depression and anxiety in people with inflammatory bowel disease , 2001, Journal of epidemiology and community health.

[21]  D. Fergusson,et al.  Asthma and depressive and anxiety disorders among young persons in the community , 2004, Psychological Medicine.

[22]  E. Fuller-Thomson,et al.  Depression and inflammatory bowel disease: Findings from two nationally representative Canadian surveys , 2006, Inflammatory bowel diseases.

[23]  T. Belin,et al.  Psychotropic medication use among children in foster care: relationship to severe psychiatric disorders. , 1999, American journal of public health.

[24]  Robert G Maunder,et al.  The role of stress in the development and clinical course of inflammatory bowel disease: epidemiological evidence. , 2008, Current molecular medicine.

[25]  Adrian Angold,et al.  Childhood and adolescent psychiatric disorders as predictors of young adult disorders. , 2009, Archives of general psychiatry.

[26]  L. Lix,et al.  The Manitoba IBD Cohort Study: A Population-Based Study of the Prevalence of Lifetime and 12-Month Anxiety and Mood Disorders , 2008, The American Journal of Gastroenterology.

[27]  I. Engström.  Inflammatory bowel disease in children and adolescents: mental health and family functioning. , 1999 .

[28]  R. King.  Pediatric inflammatory bowel disease. , 2003, Child and adolescent psychiatric clinics of North America.

[29]  E. Szigethy,et al.  Strategies to improve quality of life in adolescents with inflammatory bowel disease , 2009, Inflammatory bowel diseases.

[30]  L. Lix,et al.  Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease , 2008, Inflammatory bowel diseases.

[31]  E. Loftus.  The epidemiology and natural history of Crohn’s disease in population-based patient cohorts from North America: a systematic review , 2001 .

[32]  Ali H Mokdad,et al.  Depression and anxiety in the United States: findings from the 2006 Behavioral Risk Factor Surveillance System. , 2008, Psychiatric services.

[33]  A. Zinsmeister,et al.  Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. , 1998, Gastroenterology.

[34]  M. Artés,et al.  Burden of illness of Crohn's disease in Spain. , 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[35]  Alan Apter,et al.  Psychiatric aspects of pediatric cancer. , 2003, Child and adolescent psychiatric clinics of North America.

[36]  J. Andrews,et al.  Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: A literature review , 2007, Inflammatory bowel diseases.

[37]  D. Pine,et al.  The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. , 1998, Archives of general psychiatry.

[38]  D. Patel,et al.  Suicide risk in adolescents with chronic illness: implications for primary care and specialty pediatric practice: a review , 2010, Developmental medicine and child neurology.

[39]  P. Mcgrogan,et al.  Effect of Testosterone Therapy for Delayed Growth and Puberty in Boys with Inflammatory Bowel Disease , 2010, Hormone Research in Paediatrics.

[40]  E. Iobst,et al.  Profile of depression in adolescents with inflammatory bowel disease: Implications for treatment , 2009, Inflammatory bowel diseases.

[41]  E. Brown.  Effects of Glucocorticoids on Mood, Memory, and the Hippocampus , 2009, Annals of the New York Academy of Sciences.

[42]  R. Mojtabai.  Diagnosing Depression and Prescribing Antidepressants by Primary Care Physicians: The Impact of Practice Style Variations , 2002, Mental health services research.

[43]  A. Caspi,et al.  Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. , 2003, Archives of general psychiatry.

[44]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.